L-Theanine for Health & Longevity - Quick Reference Sheet

L-Theanine for Health & Longevity

Created on 10/22/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5.5 – Audit

L-Theanine, a tea amino acid sold as an inexpensive supplement for calm, focus and sleep, briefly, slightly sharpens attention within an hour of dosing. Effects on stress, sleep quality and low mood are small and inconsistent; people may feel they sleep better without sleeping longer. Side effects were mild and uncommon at tested doses. Most trials are small, short, often company-funded; any role in slowing aging rests on animal data. (Full Review)

Protocol

Daily stress and sleep support
200–400 mg/day
200 mg/day for 4 weeks; up to 400 mg/day for people under stress
Acute focus
200 mg single dose
30–60 minutes before cognitive work
Pre-sleep use
100–400 mg
30–60 minutes before bed
Time to effect
Attention
30–60 minutes
after a single dose
Sleep
4 weeks
of daily use
Stress
4 weeks
of daily use; acute calming 30–60 minutes after a dose

Benefits

Contraindications
  • Pregnant or breastfeeding women (no human safety data)
  • People with symptomatic low blood pressure (theoretical)
  • People undergoing chemotherapy, unless the treating oncologist agrees (theoretical, animal data)
  • People with sleepwalking or night terrors (practitioner caution; no controlled data)
Key Interactions
  • Blood-pressure medications (amlodipine, lisinopril): Monitor (theoretical)
  • Benzodiazepines and sleep medications (alprazolam, zolpidem): Caution (theoretical)
  • Stimulants (caffeine, methylphenidate): Monitor
  • Antidepressants and antipsychotics (sertraline, risperidone): Monitor
  • Over-the-counter sleep aids (diphenhydramine, doxylamine): Caution (theoretical)
  • Calming supplements (GABA, melatonin): Monitor (theoretical)
  • Blood-pressure-lowering supplements (garlic, hibiscus): Monitor (theoretical)
  • Alcohol: Caution (theoretical)

Risk & Side Effects

  • High:
  • Medium: Lower maximal strength shortly after a dose
  • Low: Mild adverse events; shorter total sleep time
  • Speculative: Additive blood-pressure lowering; vivid dreams and sleep disturbances; altered chemotherapy drug levels; kidney tumors in high-dose rats

Monitoring

Marker Target Why
Home blood pressure No established target; change from own 1-week baseline Safety check: additive lowering with blood-pressure drugs
PSQI sleep score ≤5 Expected to change: sleep quality
GAD-7 anxiety score <5 Expected to change: anxiety symptoms
Wearable total sleep time No established target; change from own 2-week baseline Safety check: shorter sleep seen in one trial

Cadence: Home blood pressure three times weekly for the first 2 weeks; questionnaires at 4 weeks, then every 3 months; continuous wearable sleep tracking during the first 4 weeks

Qualitative Assessment

  • Perceived calm during stressful tasks
  • Ease of falling asleep and morning refreshment
  • Focus and absence of jitteriness when paired with caffeine
  • Dream intensity and night waking
  • Headache, dry mouth or digestive symptoms